Barclays
OPK icon

Barclays’s Opko Health OPK Stock Holding History

Barclays’s Portfolio OPK Stock Details OPK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-1,200
Closed -$2K – 6371
2019
Q4 		$2K Hold
1,200
– – ﹤0.01% 6245
2019
Q3 		$3K Hold
1,200
– – ﹤0.01% 6511
2019
Q2 		$3K Hold
1,200
– – ﹤0.01% 6769
2019
Q1 		$3K Sell
1,200
-20,100
-94% -$60.9K ﹤0.01% 6810
2018
Q4 		$64K Sell
21,300
-38,400
-64% -$130K ﹤0.01% 5341
2018
Q3 		$207K Buy
59,700
+23,000
+63% +$122K ﹤0.01% 4969
2018
Q2 		$172K Buy
36,700
+1,300
+4% +$4.93K ﹤0.01% 4844
2018
Q1 		$112K Sell
35,400
-97,900
-73% -$394K ﹤0.01% 5306
2017
Q4 		$653K Buy
133,300
+2,100
+2% +$12.2K ﹤0.01% 3541
2017
Q3 		$900K Buy
131,200
+63,200
+93% +$398K ﹤0.01% 3098
2017
Q2 		$447K Buy
68,000
+25,000
+58% +$175K ﹤0.01% 3636
2017
Q1 		$344K Sell
43,000
-30,200
-41% -$254K ﹤0.01% 3779
2016
Q4 		$681K Buy
73,200
+14,700
+25% +$152K ﹤0.01% 3105
2016
Q3 		$620K Buy
58,500
+33,900
+138% +$338K ﹤0.01% 3049
2016
Q2 		$230K Sell
24,600
-216,300
-90% -$2.2M ﹤0.01% 3826
2016
Q1 		$2.41M Sell
240,900
-4,834,275
-95% -$44.2M ﹤0.01% 1751
2015
Q4 		$50.8M Sell
5,075,175
-748,500
-13% -$7.5M 0.06% 276
2015
Q3 		$46.6M Sell
5,823,675
-1,246,225
-18% -$16.5M 0.06% 301
2015
Q2 		$113M Buy
7,069,900
+725,100
+11% +$11.3M 0.13% 126
2015
Q1 		$88.8M Buy
6,344,800
+3,490,700
+122% +$45.4M 0.1% 178
2014
Q4 		$25.7M Buy
2,854,100
+1,051,200
+58% +$9M 0.02% 636
2014
Q3 		$14.4M Sell
1,802,900
-1,316,300
-42% -$11.6M 0.01% 920
2014
Q2 		$25M Buy
3,119,200
+589,500
+23% +$5.15M 0.03% 587
2014
Q1 		$22.8M Sell
2,529,700
-834,100
-25% -$7.31M 0.03% 616
2013
Q4 		$26.9M Buy
3,363,800
+2,359,300
+235% +$23.8M 0.03% 599
2013
Q3 		$8.04M Buy
1,004,500
+214,700
+27% +$1.72M 0.01% 1316
2013
Q2 		$5.61M Buy
+789,800
New +$5.45M 0.01% 1527

Other funds holding OPK

BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $463B AUM
AIC
AWM Investment Company New York $1.04B AUM 103.31% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return
Washington Growth Strategies
Washington Growth Strategies Washington, District of Columbia $183M AUM 21.53% 1-Year Est. Return

Barclays's OPK Position: Q3 2026 in Review

Barclays increased its Opko Health (OPK) stake by 150% in Q3 2026, buying an estimated $216K and bringing the position to 248,608 shares worth $400K. The position accounts for ﹤0.01% of the portfolio, ranked #3591.

Barclays first reported a position in OPK in Q2 2013 and has held it in 54 quarters since. The position peaked at $19.4M in Q4 2015. 174 funds tracked by Wall St. Rank hold OPK as of Q3 2026.

  • Barclays held 248,608 shares of Opko Health worth $400K as of Q3 2026.
  • Barclays bought 149,012 Opko Health shares in Q3 2026, an estimated $216K.
  • Opko Health made up ﹤0.01% of Barclays's portfolio in Q3 2026, its #3591 holding.
  • Barclays first reported a position in Opko Health in Q2 2013 and has held it in 54 quarters since.
  • Barclays's Opko Health position peaked at $19.4M in Q4 2015.
  • 174 funds tracked by Wall St. Rank held Opko Health as of Q3 2026.

Based on Barclays's 13F filing for Q3 2026, filed 6 Nov 2026.